Myhre Syndrome in the Practice of an Obstetrician-Gynecologist: a Clinical Case

Myhre syndrome is an extremely rare genetic disease of connective tissue characterized by multisystem lesion, progressive and proliferative fibrosis, mental retardation. The pathogenesis is based on a mutation of the SMAD4 gene, which leads to the proliferation of abnormal fibrous tissues. The main manifestations of pathology are growth deficiency, peculiar facial features (short eye slits, hypoplasia of the middle third, prognathism), mental retardation, lesions of the musculoskeletal system, ophthalmological disorders, sclerodermic manifestations, hearing loss, pathology of the cardiovascular, respiratory system and other organs and systems. Etiotropic and pathogenetic therapy has not been developed at the moment, treatment is exclusively symptomatic. The presented clinical case of a patient with Myhre syndrome clearly demonstrates the need for an interdisciplinary approach to the diagnosis and treatment of this disease. It should also be noted the importance of spreading knowledge about rare hereditary pathology among doctors of various specialties for timely diagnosis and selection of symptomatic therapy.

Authors

Publication Details

Journal
Effective Pharmacotherapy
Published
2024-10-27
DOI
https://doi.org/10.33978/2307-3586-2024-20-35-58-61
Primary Topic
Maternal and Perinatal Health Interventions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Myhre Syndrome in the Practice of an Obstetrician-Gynecologist: a Clinical Case

Yu.A. Kirillova, Irina V. Karachentsova, Ye.V. Pavlova, I.A. Melenchuk et al.
Effective Pharmacotherapy
Maternal and Perinatal Health Interventions
article

Myhre Syndrome in the Practice of an Obstetrician-Gynecologist: a Clinical Case

Yu.A. Kirillova, Irina V. Karachentsova, Ye.V. Pavlova, I.A. Melenchuk, Ye.V. Sibirskaya
article en

Abstract

Myhre syndrome is an extremely rare genetic disease of connective tissue characterized by multisystem lesion, progressive and proliferative fibrosis, mental retardation. The pathogenesis is based on a mutation of the SMAD4 gene, which leads to the proliferation of abnormal fibrous tissues. The main manifestations of pathology are growth deficiency, peculiar facial features (short eye slits, hypoplasia of the middle third, prognathism), mental retardation, lesions of the musculoskeletal system, ophthalmological disorders, sclerodermic manifestations, hearing loss, pathology of the cardiovascular, respiratory system and other organs and systems. Etiotropic and pathogenetic therapy has not been developed at the moment, treatment is exclusively symptomatic. The presented clinical case of a patient with Myhre syndrome clearly demonstrates the need for an interdisciplinary approach to the diagnosis and treatment of this disease. It should also be noted the importance of spreading knowledge about rare hereditary pathology among doctors of various specialties for timely diagnosis and selection of symptomatic therapy.

Effective PharmacotherapyVol. 20(35)
Openalex Percentile: Top 63%
Maternal and Perinatal Health Interventions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.